Revenue Growth

Oracle is launching a massive ad campaign for its Project Jupiter data center, promising billions. But can it win over a divided community wary of its water use?

Amid a S$50B construction surge, one firm's logistics overhaul and green tech pivot reveal the strategy needed to power Singapore's ambitious future.

A new report reveals Europe's medically-focused cannabis market is finally waking, creating a new global blueprint but also intense competition and price wars.

A top financial forum is urging a GST hike, corporate tax cuts, and a radical revamp of retirement savings in its bold 2026 federal budget proposal.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

With strong clinical data for its Dayspring system, Koya Medical is pitching to investors to fund the next phase of growth for its patient-centered tech.

Growth equity firm AVANT BIO adds biomanufacturing legends Maik Jornitz and Lukas Utiger, signaling a shift toward deep operational support for its startups.

A landmark $306M investment from Tenaris, backed by government, promises to create jobs, bolster energy independence, and modernize Canadian manufacturing.

Boca Raton-based Proforce Pest Control lands on the PCT Top 100 list, but can its customer-first philosophy keep pace with its explosive 558% growth?

With the 2026 World Cup looming, the Jersey-based chain partners with Olympian Kaylyn Kyle in a strategic move blending authentic endorsement with expansion.

Quanex will report Q2 results on June 4, with investors watching for updates on its Tyman integration and performance in a tough building market.

With booming revenue and a new premium product on the horizon, Grindr's CFO is set to outline the company's ambitious future to investors this month.

The JOi Dollar Plus operator is upsizing its convertible debt offering, signaling strong investor confidence and a strategic pivot to retire senior debt.

At SLAS 2026, MGI Tech unveiled intelligent platforms for proteomics and clinical automation, signaling a major push to accelerate scientific discovery.

After unprecedented growth, Clear Fork Bank names a new CEO known for community ties, signaling a strategy to blend legacy values with future expansion.

Pan-Asian brand Mr Bing is turning up the heat with a new BBQ line built on chili crisp and gochujang, aiming to redefine the American grilling staple.

A powerful new combination therapy from Junshi Biosciences and RemeGen gains approval in China, offering unprecedented hope for urothelial carcinoma patients.

As X Financial prepares its Q1 2026 results, investors are watching closely after a tough Q4 and amid China's harsh new fintech regulations.

With final court approval, Crescita Therapeutics will be delisted from the TSX as global platform ClinActiv snaps up its dermatology assets.

Celebrating a half-century of progress, Liberty Hill Foundation's anniversary gala was an urgent plea to fund the fight for Los Angeles's future.